chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever on and off for 5 days now starting 5 days after receiving MMR, Varicella and Hepatitis A vaccine. red maculo papular rash on the face, trunk and extremity today.
No adverse event.  A Covid booster shot was given 2 weeks early. 2nd vaccine was given on 3/25/22 and a booster on 8/12/22.  Contacted CDC and was advised to repeat the booster dose at a 3-month minimum interval.  The child's mother is notified of the information. No medical problem/AE was found with the child per mom.
Patient complained of aching bones, fever, can't get warm, off balance, slept for 2 days - resolved after 4 days. Shot location - knotted up and pain - continues.
Pt vaccinated with DTP one of set of twins developed a cough w/no fever 4 days after 1st immunization. On exam cough w/cyanosis, chest x-ray clear. Tavist prescribed. Cough worsened. Hospitalized started on erythromycin.
This spontaneous report as received from a pharmacist refers to a newborn (male) patient of unknown age. On 15-OCT-2012 13:08, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
PT COMPLAINED OF THROAT THIGHTNESS AFTER VACCINE ADMISNTRATION . PT HAD WATER WAS ANXIOUS DUE TO PREEXISTING CONDITION-GBS. PT WAS CLEARED BY DOCTOR TO RECEIVE VACCINE. PT'S BP AND PULSE WAS ASSESSED. PT FELT BETTER AFTER WAITING OUT
After booster dose, I had a high fever for several days.  Three days later I had a stroke, was hospitalized for three days and sent to a rehab facility for an additional 10.  Not at all sure the two are related - in fact not sure anyone realized the stroke came so soon after my vaccination. Probably more likely related to TAVR procedure the month before (10/7/21) but it seemed worth reporting.  I?ve been told my stroke is listed as ?unexplained.?
pt recv vax 24OCT97 & 11NOV97 pt exp numbness of legs, suspecting GBS pt returned to Brazil;MD in Brazil feel that its related to flu vax;pt had trouble swallowing & was on a liquid diet;pt reportedly wheelchair bound & could not walk;
After dinner patient started to feel nauseous and warm, later that evening she developed a high fever (Mom did not take), chills, dizziness and weakness. Mom did pack her in ice to bring the fever down and gave Motrin. In the morning she was still feeling weak, dizzy, running a fever of 101.6 now even with Motrin in her and nauseated. Mom giving fluids and fever reducers as needed.
Fever (102), mild nausea, headaches, myalgias, fatigue, pain/stiffness at injection site, swelling of arm -6/10/17 TYLENOL PRN, red, Hydroxyzine HCL 25 mg 1-2 every 6 hours PRN itching. Sx improving not gone.
Hospitalized by 1st seizure < 24 hrs, shaky body, ?, MD seizure < 48 hrs. Brought to EMT-longer duration-admitted to hospital w/U (-) culture (-) CT scan. Seen by neurologist started on phenobarbital.  Information received from discharge summary states tremor, eyes rolled back, post ictal. msv
10 days after the injection I had a small itchy rash at injection site. The next day it was the size of your hand palm, red hot and swollen. The next day it was from my elbow to my shoulder.  No fever or any temperature. The outline is still on my arm  11 days later, but not hot or swollen.
devel a cerebral hemisphere stroke w/diff speech & rt arm weakness;pt concerned w/immune problems w/lupus-type effect have caused a vasculitis & injured peripheral nerves & some CNS;MD felt poss mixed collagen disease;paresthesia
pt recv vax 15JUN98 2PM & 4hr later weak, tired, cramps, h/a, GI upset, nausea, fever, slept 12hr;cont fever next day, lethargic;still feels a bit run down 48hr later;
This spontaneous report as received from a pharmacy healthcare student, refers to a 65 year old patient of unknown gender. On 31-OCT-2013 the patient was vaccinated with ZOSTAVAX (lot # J001729, expiration date 20-OCT-2013) (dose, indication and route were not reported), which was approximately 10 days after the expiration. Concomitant medications were not reported. No adverse effect reported. Additional information has been requested.
magnet and keys stick to my arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (magnet and keys stick to my arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (magnet and keys stick to my arm). At the time of the report, VACCINATION SITE REACTION (magnet and keys stick to my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported , No treatment medication was reported .
Received Pfizer vaccines on 3/30/21, 4/21/21 tested positive for COVID by PCR on 7/29/21.
Fever, chills, body aches, joint pain and swelling, pain at injection site, headache and nausea
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 73-year-old male patient who received SHINGRIX (batch number PK9BY, expiry date unknown) for prophylaxis. On 28th September 2018, the patient received the 1st dose of SHINGRIX. On 30th September 2018, 2 days after receiving SHINGRIX, the patient experienced injection site pain, numbness in fingers and injection site warmth. On an unknown date, the outcome of the injection site pain, numbness in fingers and injection site warmth were recovered/resolved. It was unknown if the reporter considered the injection site pain, numbness in fingers and injection site warmth to be related to SHINGRIX. Additional details were provided as follows: The patient received the vaccine in an unknown arm. The expiration date could not be located. The patient experienced numbness in his fingers and toes, about 2 days after the injection. The patient also had a mild temperature and pain at injection site. The reporter consented to follow up. The reported batch number for SHINGRIX (EK9BY) did not exist and was updated to PK9BY as per sales database. For tolerance to 2nd dose refer case US2019019199.
Full body muscle soreness; Fatigue; Swollen and tender lymph nodes under left arm (arm of injection site) and left neck; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Jun2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to sulfa drugs. The patient had known allergies to ceftriaxone sodium (ROCEPHINE). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Jun2021, 12 hours after vaccination, the patient experienced full body muscle soreness, fatigue and swollen and tender lymph nodes under left arm (arm of injection site) and left neck for 2-3 weeks post vaccine. The patient's lymph nodes were slightly enlarged but no longer tender at the time of report. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events full body muscle soreness and fatigue was resolved with sequelae on an unknown date in Jun2021, after the duration of 12 hours; while that of the swollen and tender lymph nodes under left arm (arm of injection site) and left neck was not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
3/12/03(PM) Developed uticaria beginning near right eye and and becoming widespread progressing to trunk and extremities. Light headed with headache. Seen by physician and treated with Benadryl. 03/15/03 uticaria decreasing  03/16/03 Uticaria resolved.
This spontaneous report was received from a nurse, who was also the patient's mother, via a company representative concerning to her daughter a 18 year old female patient. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported. In July 2016 (reported as "about 6 months ago"), the patient was vaccinated with the first dose of GARDASIL 9 (dose, route, anatomical location, lot number and expiration date were not reported) for prevention of human papillomavirus (HPV); the reporter indicated that there was not adverse experiences reported at that time. In September 2016 (reported as 2 months later), the patient was vaccinated with the second dose of GARDASIL 9 in an arm (dose, route, lot number and expiration date were not reported) for prevention of HPV and with an unspecified dose of influenza virus vaccine inactivated (unspecified), which was administered in the other arm (dose, route, lot number and expiration date were not reported) for prophylaxis. On an unknown date, the patient experienced a huge knot on the arm  where the HGARDASIL 9 was administered and a bad rash on her upper body (arms and torso). It was reported that the patient sought medical attention on an unknown date, however it was unknown whether treatment was given for the adverse events or laboratory diagnostics studies were performed. Then, on an unknown date, after 2 weeks, the patient recovered from both events. It was reported that the patient was reviewing the situation with her physician and trying to decide if she would get a third dose of GARDASIL 9. A product quality complaint was not involved. The causal relationship between the events and GARDASIL 9 and influenza virus vaccine inactivated (unspecified) was not reported. Additional information has been requested.
Skin reaction; This case was reported by a physician via call center representative and described the occurrence of skin reaction in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced skin reaction. On an unknown date, the outcome of the skin reaction was unknown.   It was unknown if the reporter considered the skin reaction to be related to Shingrix.  Additional details were provided as follows:  The age at vaccination was not reported. The batch number and expiration date were not available since the vaccine was administered in a different facility.  The reporter consent to follow up.
Headache lasting all day. I took a Nurtec and it lessened. 6hrs later I took 2 500mg Tylenol. I lessened for a little.
pt recvd vax 16MAY94, rash devel on both legs @ inject site & have inc become worse spreading down both legs w/pruritus; afebrile advised f/u on the TC of 20MAY94;
pt recvd vax & devel myalgias, tingling all over & body laryngeal edema; tx'd w/Adrenalin (1/4 ml SQ) & DPH; pt improved significantly w/in 30 mins; next day pt reported to MD was still a little hoarse
Patient presented to pharmacy on 5/19/21 showing large rash around jawline and another similar rash on the back of the leg. Looks similar in pattern to ringworm- large round welts. Did not seem to be raised but was pink in color. Patient said they were itchy. This began 1 day post vaccine on 5/3/21. She went to an urgent care on 5/6/21 when rash was not going away. She was prescribed clotrimazole/betamethasone cream and cetirizine. As of 5/19/21, rash still persists. She had concerns regarding what would happen when she got her second dose.
Fever, skin irritation/sensitivity, fatigue, brain fog, sore throat, gunky throat, headache. Significantly sore arm (going on 5 days)
The next day it felt like someone had beat me up. I had total body aches I felt like I was a punching bag; headaches were the worst. They were exploding. It was the worst headache I ever, ever had and I get migraines all the time. Body aches went away by Monday afternoon or Tuesday morning. Headaches still continued for about three weeks but not like the initial ones. I still get the headaches today. I called the doctor and he said it was a common side effect. Advil Liquid gels is what I took for the pain and I needed them for a while. By April, I was okay, but my headaches were more intense than before the vaccine. Then in May, about the 12th, I lost my voice. I was rasping or trying to speak. No one could understand me.  There was a cough in my chest. My voice still fluctuates but it is back. It's just deeper and it's not completely back - I sound like I'm winded but I'm not winded physically at all. I called my doctor and spoke with nurse, and they gave me Levaquin, but I already had some and it was 500 mg for five days. Heaviness in my lungs went away even though voice was still raspy. Just waiting now for the voice to come back completely.
Day 1: Day of vaccination on left arm. No significant reaction except soreness of arm arm. Day 2: General malaise and chills Day 3- symptoms resolve  Adverse events started day 8th of vaccine administration  on 1/13 2021. First noticed at around 5 AM. Hard injection site- red and warm. slight improvement with ibuprofen 1/13 /2021: visited urgent care where it was suspected a potential reaction to vaccine. prescribed benadryl and told to continue take Ibuprofen 1/14/2021: site redness diffused and increased/ spread. heat remained. no significant pain. infection of site was ruled out adn was advised to continue Benadryl and ibuprofen 1/15/2021: continued Benadryl every 4-6 hours with 600mg IB - slight improvement in color and area of redness skipped benadryl 1/16, 1/17 but redness came back and site was hot to touch. Area is now increased.  1/18: took benadryl and IB again with improvement in symptoms with redness improved but arm feels sore. 1/19: infection again ruled out this morning and it was suggested to report to VAERS and Employee health services of the employer and refer to immunology and allergy. at this time, i am continuing to take banadryl and and IB  and made an appt with allergy specialist. I have My PMD visit tomorrow at 3:30 PM.
Extreme vertigo for 36 hours, lingering vertigo for 5 days; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an unspecified route of administration in the left arm on 24Feb2021 at 09:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included opioid allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamin d (MANUFACTURER UNKNOWN) and ascorbic acid (VITAMIN C); both for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Feb2021 at 17:30, the patient experienced extreme vertigo for 36 hours and lingering vertigo for 5 days. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extreme vertigo for 36 hours and lingering vertigo for 5 days was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Vertigo, nausea, extreme swelling, rash size of baseball around injection site, inability to lift or lower arm of injection site, hard knot (baseball size), fever of 100.5 and remaining body joints hurt as well. Sinus drainage and coughing mucus began on day 2. Reaction continued for 3 days, treated with Benadryl & fluids.  Fever broke after day 2. Rash improved after day 4. Soreness continues today.
inappropriate schedule; Injection site welt 3 inch wide half inch tall; This case was reported by a nurse via call center representative and described the occurrence of injection site wheal in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 19th October 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The nurse reported that a patient was late for their second dose of Shingrix after receiving the first dose, which led to lengthening of vaccination schedule.  The reason for the late dose was unknown. The reporter had consented to follow up.   Follow up information was received from the nurse on 16th July 2019: The patient's demographic details were updated. On 19th October 2018, the patient received the 1st dose of Shingrix (intramuscular) and less than a day after receiving 1st dose of Shingrix, the patient experienced injection site wheal. On 1st April 2019, the outcome of the injection site wheal was recovered. The reporter considered the injection site wheal to be almost certainly related to Shingrix. On 6th May 2019, the patient received the 2nd dose of Shingrix and not cause any side effect or adverse event. 2nd dose was given by the same nurse and no side effect noted or reported by nurse or patient. The patient was not allergic to the Shingrix vaccine but the technique of administration as well as the intensity of the vaccine itself may have been compromised. The reporter stated that the office did not stored the documentation of specific vial of Shingrix used on 19th October 2018. Reason for delayed in receiving 2nd dose was unknown and probably a fault of administration. The reporter was asking about how to complete information and if it was necessary. The reporter explained reason for follow up. The reporter encouraged completion of healthcare professional information on adverse event reported. The reporter reported no documentation of lot number was done at healthcare professional office.
Syncope reaction following vaccine administration. Patient recovered within seconds. Patient was flushed and vomited once. Severe anxiety prior to shot administration.
Approximately 12 hours after vaccine, noted discomfort and redness around but more distal to injection site. Denies swelling in area. 36 hours after injection reported red area 4 1/2" x 2" in size - still no swelling just hot and red. Reported to PCP. Took Ibuprofen prn.
Woke up with whole body aching, arm slightly sore at shot area. Weak and felt like the Flu symptoms. By Day 2 was coughing and day three went to Dr.s and said I had a lung infection, bronchitis. I was subscribed antibiodics and was bedridden for several days, fever and sweats, etc.  Today is 1/15/2016 and still have weakness and coughing. Phlegm  included blood streaks, which is going to be addressed.  It's hard to believe the live virus I was admimistered didn't have anything to do with the shot.
Shot given 11/14/12 at 3:00 pm, awoke 11/15/12 at 6:00 am with extreme edema of the face. Took 25 mg of BENADRYL 11/15/12 & slept. Still swollen 11/16/12. Spouse reports better 11/16/12.
second vaccine felt cold when it was given; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE COLDNESS (second vaccine felt cold when it was given) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Blood pressure high since an unknown date.    In February 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE COLDNESS (second vaccine felt cold when it was given). At the time of the report, VACCINATION SITE COLDNESS (second vaccine felt cold when it was given) outcome was unknown.            Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.  The patient toll the flu vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 20-Oct-2021: Follow up received on 20 oct 2021 relevant information updated in the I narrative.
Fever; muscle aches; rash on /abdomen and face; This case was reported by a consumer via call center representative and described the occurrence of fever in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th July 2021, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 15th July 2021, less than a day after receiving Shingrix, the patient experienced fever, muscle pain and rash. On 18th July 2021, the outcome of the fever and muscle pain were recovered/resolved. On an unknown date, the outcome of the rash was not recovered/not resolved.   It was unknown if the reporter considered the fever, muscle pain and rash to be related to Shingrix.  Additional information was provided as follows: The case was reported by patient herself. The patient experienced fever and muscle ache which  started on the 15th July 2021 and lasted until the 18th July 2021.   She also experienced a rash on her abdomen and face starting on the 15th that had not resolved yet.  No lot number or expiration date was known. The reporter did not consent to follow-up.